Finder may earn compensation from partners, but editorial opinions are our own. Advertiser Disclosure

How to buy Akoya Biosciences stock | $12.98

Learn how to easily invest in Akoya Biosciences stock.

Akoya Biosciences Inc is a medical instruments & supplies business based in the US. Akoya Biosciences shares (AKYA) are listed on the NASDAQ and all prices are listed in US Dollars. Akoya Biosciences employs 169 staff and has a trailing 12-month revenue of around 0.00.

How to buy shares in Akoya Biosciences

  1. Compare share trading platforms.Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – AKYA – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

Akoya Biosciences stock price (NASDAQ: AKYA)

Use our graph to track the performance of AKYA stocks over time.

Akoya Biosciences shares at a glance

Information last updated 2021-10-17.
Latest market close$12.98
52-week range$12.07 - $28.96
50-day moving average $14.98
200-day moving average $18.03
Wall St. target price$26.00
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) $-2.94

Buy Akoya Biosciences shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Asset types Option trade fee Annual fee Signup bonus
Stocks, Options, ETFs, Cryptocurrency
Free stock (chosen randomly with a value anywhere between $2.50 and $200)
Sign up using the "go to site" link
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
J.P. Morgan Self-Directed Investing
Stocks, Bonds, Options, Mutual funds, ETFs
$0 + $0.65/contract
Sofi Invest
Stocks, ETFs, Cryptocurrency
Get one free stock worth up to $1,000
Open an account
A free way to invest in stocks, ETFs and crypto.
Vanguard Personal Advisor
Stocks, Options, Mutual funds, ETFs
$20 per year
Financial advice powered by relationships, not commissions.
Stocks, Bonds, Options, Mutual funds, ETFs, Cryptocurrency
$0 + $0.50/contract
$0 per month
Deposit qualifying assets of $5,000+
A platform built for all kinds of traders and all styles of trading
$0 per year
Get a free stock valued up to $350
Open your Futu brokerage account via Moomoo
Trade stocks on the US, Hong Kong, Shanghai and Shenzhen markets.

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Akoya Biosciences stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Akoya Biosciences price performance over time

Historical closes compared with the close of $12.98 from 2021-10-18

1 week (2021-10-12) 6.05%
1 month (2021-09-20) -32.68%
3 months (2021-07-20) -25.53%
6 months (2021-04-20) -43.86%
1 year (2020-10-16) N/A
2 years (2019-10-16) N/A
3 years (2018-10-16) N/A
5 years (2016-10-16) N/A

Akoya Biosciences financials

Revenue TTM $48.1 million
Gross profit TTM $25.9 million
Return on assets TTM -8.6%
Return on equity TTM -63.92%
Profit margin -49.07%
Book value $3.98
Market capitalisation $471.9 million

TTM: trailing 12 months

Shorting Akoya Biosciences shares

There are currently 592,043 Akoya Biosciences shares held short by investors – that's known as Akoya Biosciences's "short interest". This figure is 36.9% up from 432,500 last month.

There are a few different ways that this level of interest in shorting Akoya Biosciences shares can be evaluated.

Akoya Biosciences's "short interest ratio" (SIR)

Akoya Biosciences's "short interest ratio" (SIR) is the quantity of Akoya Biosciences shares currently shorted divided by the average quantity of Akoya Biosciences shares traded daily (recently around 95030.979133226). Akoya Biosciences's SIR currently stands at 6.23. In other words for every 100,000 Akoya Biosciences shares traded daily on the market, roughly 6230 shares are currently held short.

To gain some more context, you can compare Akoya Biosciences's short interest ratio against those of similar companies.

However Akoya Biosciences's short interest can also be evaluated against the total number of Akoya Biosciences shares, or, against the total number of tradable Akoya Biosciences shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Akoya Biosciences's short interest could be expressed as 0.02% of the outstanding shares (for every 100,000 Akoya Biosciences shares in existence, roughly 20 shares are currently held short) or 0.0357% of the tradable shares (for every 100,000 tradable Akoya Biosciences shares, roughly 36 shares are currently held short).

A SIR below 10% would generally be considered to indicate a fairly optimistic outlook for the share price, with fewer people currently willing to bet against Akoya Biosciences.

Find out more about how you can short Akoya Biosciences stock.

Akoya Biosciences share dividends

We're not expecting Akoya Biosciences to pay a dividend over the next 12 months.

Akoya Biosciences overview

Akoya Biosciences, Inc. , a life sciences technology company, provides spatial biology solutions focused on transforming discovery and clinical research. The company offers single-cell imaging solutions that allow researchers to phenotype cells with spatial context and visualize how they organize and interact to influence disease progression and treatment response. It provides two distinct solutions, the CODEX and Phenoptics platforms, to serve the diverse needs of researchers across discovery, translational, and clinical research. The company was incorporated in 2015 and is headquartered in Marlborough, Massachusetts. .

Frequently asked questions

What percentage of Akoya Biosciences is owned by insiders or institutions?
Currently 55.422% of Akoya Biosciences shares are held by insiders and 71.632% by institutions.
How many people work for Akoya Biosciences?
Latest data suggests 169 work at Akoya Biosciences.
When does the fiscal year end for Akoya Biosciences?
Akoya Biosciences's fiscal year ends in December.
Where is Akoya Biosciences based?
Akoya Biosciences's address is: 100 Campus Drive, Marlborough, MA, United States, 01752
What is Akoya Biosciences's ISIN number?
Akoya Biosciences's international securities identification number is: US00974H1041

More guides on Finder

Ask an Expert

You are about to post a question on

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site